{"doi":"10.1093/europace/euab065","title":"2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation","abstract":"CV Cardiovascular CYP Cytochrome P (CYP) Unfractionated heparin ULN Upper limit of normal VENTURE-AF Active-controlled multi-center study with blind-adjudication designed to evaluate the safety of uninterrupted Rivaroxaban and uninterrupted vitamin K antagonists in subjects undergoing catheter ablation for non-valvular Atrial Fibrillation VHD Valvular heart disease VKA Vitamin K antagonist VTE Venous thromboembolic event WOEST What is the Optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation and coronary stenting X-VeRT Explore the efficacy and safety of once daily oral rivaroxaban for the prevention of cardiovascular events in patients with non-valvular atrial fibrillation scheduled for cardioversion a SmPC: 110 mg BID if age > _80 years, concomitant verapamil (both based on pharmacokinetics/pharmacodynamics analyses; not studied in this setting). b Not specifically studied, follow-up data available up to 12 months in phase III trial. c SmPc: 20 mg QD in patients at high risk of recurrence. 2021 EHRA Practical Guide on the use of NOACs AF, atrial fibrillation; CrCl, creatinine clearance; INR, international normalized ratio; NOAC, non-vitamin K antagonist oral anticoagulant; NSAID, non-steroidal anti-inflammatory drug; TIA, transient ischaemic attack; VKA, vitamin K antagonist. For frequency of visits: see Figure 3.","journal":"EP Europace","year":2021,"id":145050,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1091,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9408,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":614660,"name":"Rónán Collins","orcid":"0000-0003-0404-8266","position":1,"is_corresponding":false},{"id":616562,"name":"Matthias Antz","orcid":null,"position":2,"is_corresponding":false},{"id":614661,"name":"Pieter Cornu","orcid":"0000-0002-4802-0241","position":3,"is_corresponding":false},{"id":614662,"name":"Lien Desteghe","orcid":"0000-0001-8641-4658","position":4,"is_corresponding":false},{"id":70534,"name":"Karl Georg Hæusler","orcid":"0000-0002-6389-5054","position":5,"is_corresponding":false},{"id":56138,"name":"Jonas Oldgren","orcid":"0000-0002-9969-3921","position":6,"is_corresponding":false},{"id":614663,"name":"Holger Reinecke","orcid":"0000-0002-4515-1609","position":7,"is_corresponding":false},{"id":616563,"name":"Vanessa Roldan-Schilling","orcid":null,"position":8,"is_corresponding":false},{"id":616564,"name":"Nigel Rowell","orcid":null,"position":9,"is_corresponding":false},{"id":614664,"name":"Peter Sinnaeve","orcid":"0000-0003-4716-5892","position":10,"is_corresponding":false},{"id":334037,"name":"Thomas Vanassche","orcid":"0000-0002-7404-8918","position":11,"is_corresponding":false},{"id":70441,"name":"Tatjana Potpara","orcid":"0000-0001-6285-6902","position":12,"is_corresponding":false},{"id":29232,"name":"A. John Camm","orcid":"0000-0002-2536-2871","position":13,"is_corresponding":false},{"id":58234,"name":"Hein Heidbüchel","orcid":"0000-0001-9301-8127","position":14,"is_corresponding":false},{"id":616565,"name":"External reviewers","orcid":null,"position":15,"is_corresponding":false},{"id":27696,"name":"Gregory Y. H. Lip","orcid":"0000-0002-7566-1626","position":16,"is_corresponding":false},{"id":344534,"name":"Thomas Deneke","orcid":"0000-0003-1379-1684","position":17,"is_corresponding":false},{"id":70442,"name":"Nikolaos Dagres","orcid":"0000-0003-0323-4956","position":18,"is_corresponding":false},{"id":614665,"name":"Giuseppe Boriani","orcid":"0000-0002-9820-4815","position":19,"is_corresponding":false},{"id":616566,"name":"Tze-Fan Chao","orcid":null,"position":20,"is_corresponding":false},{"id":614666,"name":"Eue‐Keun Choi","orcid":"0000-0002-0411-6372","position":21,"is_corresponding":false},{"id":344528,"name":"Mellanie True Hills","orcid":"0000-0001-8298-4418","position":22,"is_corresponding":false},{"id":22780,"name":"Itamar S Santos","orcid":"0000-0003-3212-8466","position":23,"is_corresponding":false},{"id":614667,"name":"Deirdre A. Lane","orcid":"0000-0002-5604-9378","position":24,"is_corresponding":false},{"id":55150,"name":"Dan Atar","orcid":"0000-0003-1513-8793","position":25,"is_corresponding":false},{"id":614668,"name":"Boyoung Joung","orcid":"0000-0001-9036-7225","position":26,"is_corresponding":false},{"id":616567,"name":"Oana Maria Cole","orcid":null,"position":27,"is_corresponding":false},{"id":616568,"name":"Mark Field","orcid":null,"position":28,"is_corresponding":false},{"id":70480,"name":"Jan Steffel","orcid":"0000-0002-1477-9153","position":0,"is_corresponding":true}],"reference_count":567,"raw_metadata":null,"created_at":"2026-07-18T23:41:52.374756Z","pmid":"33895845","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}